This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

cholesterol and ischaemic heart disease

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Cholesterol-lowering therapy is an area of medicine that has prompted heated debate and a great deal of confusion.

Hypercholesterolaemia treatment can be considered in terms of primary and secondary prevention of coronary heart disease.

In general, the treatment of choice for raised cholesterol is a statin.

NICE state that (1):

  • before offering lipid modification therapy for primary prevention, all other modifiable CVD risk factors should be considered and their management optimised if possible. Baseline blood tests and clinical assessment should be performed, and comorbidities and secondary causes of dyslipidaemia should be treated. Assessment should include:
    • smoking status
    • alcohol consumption
    • blood pressure
    • body mass index or other measure of obesity
    • fasting total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides (if fasting levels are not already available)
    • fasting blood glucose
    • renal function
    • liver function (transaminases)
    • thyroid-stimulating hormone (TSH) if dyslipidaemia is present

Reference:

Links:

The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.